en.aazsante.fr

The Largest Portal Of Health And Quality Of Life.

Brazil registers more than 3 thousand cases of malformations linked to zika

Brazil registers more than 3 thousand cases of malformations linked to zika

The Ministry of Health released on Tuesday (30) new data related to changes in growth and development of babies / children due to infection with the zika virus. According to the epidemiological bulletin, 3,037 cases were confirmed between November 8, 2015 and December 2, 2017.

In this two-year period 15,150 cases of suspected malformations caused by zika were reported, of which 1,987 (13.1% % of the total) were excluded by the ministry after careful investigation, since they did not meet the current case definitions?

Among the remaining cases and with investigation completed, in addition to the 3,037 confirmed cases (20.1%), another 6,718 were discarded (44.3%), 310 were classified as probable (2%) and 195 were considered inconclusive (1.3%)

The region that concentrated the largest number of confirmed cases was the Northeast, with 2,001 cases, followed by Southeast, with 569, and by the Midwest, with 237. The northern region recorded 179, while the South confirmed 51.

According to the bulletin, the state with the highest number of malformations in infants and children was Pernambuco (16.9%). (9.2%), Paraíba (7.4%), and Rio de Janeiro (7.4%).

What is Congenital Syndrome Zika virus?

Since 2016, the World Health Organization (WHO) has come to recognize as congenital zika virus syndrome the malformations and problems presented by infants who had mothers infected by zika during gestation. The disease is considered congenital because the symptoms are already present at birth. Microcephaly is only one of the signs these children have, but they may also have epilepsy, visual and hearing impairment, developmental impairment, and other problems associated with the nervous system.


Anvisa approves immunotherapy for the treatment of melanoma

Anvisa approves immunotherapy for the treatment of melanoma

Clinical studies have shown that anti-PD-1 immunotherapy is more effective than the anti-CTLA-4 chemotherapy and immunotherapy currently available on the market. In addition, the drug is indicated for any stage of treatment at a dose of 2mg / kg, given every three weeks, in a time of 30 minutes. Since 2014, the drug for advanced melanoma is approved in the United States.

(Health)

Anvisa evaluates ban on antibacterial soaps in Brazil

Anvisa evaluates ban on antibacterial soaps in Brazil

Recently, the Food and Drug Administration (FDA), the American agency responsible for regulating the food and the United States, has banned the use of 19 chemical ingredients present in antibacterial soaps marketed in the United States. The body has reported that substances such as triclosan, common in antibacterial liquid soaps, and triclocarban, present in most soaps in the United States.

(Health)